Search Results - "Fuller, Stewart"

Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies by Collier, Dami A., De Marco, Anna, Ferreira, Isabella A. T. M., Meng, Bo, Datir, Rawlings P., Walls, Alexandra C., Kemp, Steven A., Bassi, Jessica, Pinto, Dora, Silacci-Fregni, Chiara, Bianchi, Siro, Tortorici, M. Alejandra, Bowen, John, Culap, Katja, Jaconi, Stefano, Cameroni, Elisabetta, Snell, Gyorgy, Pizzuto, Matteo S., Pellanda, Alessandra Franzetti, Garzoni, Christian, Riva, Agostino, Elmer, Anne, Kingston, Nathalie, Graves, Barbara, McCoy, Laura E., Smith, Kenneth G. C., Bradley, John R., Temperton, Nigel, Ceron-Gutierrez, Lourdes, Barcenas-Morales, Gabriela, Harvey, William, Virgin, Herbert W., Lanzavecchia, Antonio, Piccoli, Luca, Doffinger, Rainer, Wills, Mark, Veesler, David, Corti, Davide, Gupta, Ravindra K.

“…Transmission of SARS-CoV-2 is uncontrolled in many parts of the world; control is compounded in some areas by the higher transmission potential of the B.1.1.7…”
Get full text

Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease by Bergamaschi, Laura, Mescia, Federica, Turner, Lorinda, Hanson, Aimee L., Kotagiri, Prasanti, Dunmore, Benjamin J., Ruffieux, Hélène, De Sa, Aloka, Huhn, Oisín, Morgan, Michael D., Gerber, Pehuén Pereyra, Wills, Mark R., Baker, Stephen, Calero-Nieto, Fernando J., Doffinger, Rainer, Dougan, Gordon, Elmer, Anne, Goodfellow, Ian G., Gupta, Ravindra K., Hosmillo, Myra, Hunter, Kelvin, Kingston, Nathalie, Lehner, Paul J., Matheson, Nicholas J., Nicholson, Jeremy K., Petrunkina, Anna M., Richardson, Sylvia, Saunders, Caroline, Thaventhiran, James E.D., Toonen, Erik J.M., Weekes, Michael P., Göttgens, Berthold, Toshner, Mark, Hess, Christoph, Bradley, John R., Lyons, Paul A., Smith, Kenneth G.C.

“…The kinetics of the immune changes in COVID-19 across severity groups have not been rigorously assessed. Using immunophenotyping, RNA sequencing, and serum…”
Get full text

Development of a colorimetric assay for the detection of SARS-CoV-2 3CLpro activity by Garland, Gavin D, Harvey, Robert F, Mulroney, Thomas E, Monti, Mie, Fuller, Stewart, Haigh, Richard, Gerber, Pehuén Pereyra, Barer, Michael R, Matheson, Nicholas J, Willis, Anne E

“…Diagnostic testing continues to be an integral component of the strategy to contain the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) global…”
Get more information

Human Cytomegalovirus Infection of Epithelial Cells Increases SARS-CoV-2 Superinfection by Upregulating the ACE2 Receptor by Perera, Marianne R, Greenwood, Edward J D, Crozier, Thomas W M, Elder, Elizabeth G, Schmitt, Janika, Crump, Colin M, Lehner, Paul J, Wills, Mark R, Sinclair, John H

“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has caused widespread morbidity and…”
Get full text

Effective control of SARS-CoV-2 transmission between healthcare workers during a period of diminished community prevalence of COVID-19 by Jones, Nick K, Rivett, Lucy, Sparkes, Dominic, Forrest, Sally, Sridhar, Sushmita, Young, Jamie, Pereira-Dias, Joana, Cormie, Claire, Gill, Harmeet, Reynolds, Nicola, Wantoch, Michelle, Routledge, Matthew, Warne, Ben, Levy, Jack, Córdova Jiménez, William David, Samad, Fathima Nisha Begum, McNicholas, Chris, Ferris, Mark, Gray, Jane, Gill, Michael, Curran, Martin D, Fuller, Stewart, Chaudhry, Afzal, Shaw, Ashley, Bradley, John R, Hannon, Gregory J, Goodfellow, Ian G, Dougan, Gordon, Smith, Kenneth Gc, Lehner, Paul J, Wright, Giles, Matheson, Nicholas J, Baker, Stephen, Weekes, Michael P

“…Previously, we showed that 3% (31/1032)of asymptomatic healthcare workers (HCWs) from a large teaching hospital in Cambridge, UK, tested positive for…”
Get full text

Author Correction: SARS-CoV-2 evolution during treatment of chronic infection by Kemp, Steven A., Collier, Dami A., Datir, Rawlings P., Ferreira, Isabella A. T. M., Gayed, Salma, Jahun, Aminu, Hosmillo, Myra, Rees-Spear, Chloe, Mlcochova, Petra, Lumb, Ines Ushiro, Roberts, David J., Chandra, Anita, Temperton, Nigel, Sharrocks, Katherine, Blane, Elizabeth, Modis, Yorgo, Leigh, Kendra E., Briggs, John A. G., van Gils, Marit J., Smith, Kenneth G. C., Bradley, John R., Smith, Chris, Doffinger, Rainer, Ceron-Gutierrez, Lourdes, Barcenas-Morales, Gabriela, Pollock, David D., Goldstein, Richard A., Smielewska, Anna, Skittrall, Jordan P., Gouliouris, Theodore, Goodfellow, Ian G., Gkrania-Klotsas, Effrossyni, Illingworth, Christopher J. R., McCoy, Laura E., Gupta, Ravindra K.

Get full text

Author Correction: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies by Collier, Dami A., De Marco, Anna, Ferreira, Isabella A. T. M., Meng, Bo, Datir, Rawlings P., Walls, Alexandra C., Kemp, Steven A., Bassi, Jessica, Pinto, Dora, Silacci-Fregni, Chiara, Bianchi, Siro, Tortorici, M. Alejandra, Bowen, John, Culap, Katja, Jaconi, Stefano, Cameroni, Elisabetta, Snell, Gyorgy, Pizzuto, Matteo S., Pellanda, Alessandra Franzetti, Garzoni, Christian, Riva, Agostino, Elmer, Anne, Kingston, Nathalie, Graves, Barbara, McCoy, Laura E., Smith, Kenneth G. C., Bradley, John R., Temperton, Nigel, Ceron-Gutierrez, Lourdes, Barcenas-Morales, Gabriela, Harvey, William, Virgin, Herbert W., Lanzavecchia, Antonio, Piccoli, Luca, Doffinger, Rainer, Wills, Mark, Veesler, David, Corti, Davide, Gupta, Ravindra K.

Get full text

Challenges and opportunities for conducting a vaccine trial during the COVID-19 pandemic in the United Kingdom by Török, M Estée, Underwood, Benjamin R, Toshner, Mark, Waddington, Claire, Sidhom, Emad, Sharrocks, Katherine, Bousfield, Rachel, Summers, Charlotte, Saunders, Caroline, McIntyre, Zoe, Morris, Helen, Piper, Jo, Calderon, Gloria, Dennis, Sarah, Assari, Tracy, de Rotrou, Anita Marguerie, Shaw, Ashley, Bradley, John, O’Brien, John, Rintoul, Robert C, Smith, Ian, Bullmore, Ed, Chatterjee, Krishna, Ribeiro, Carla, Pickup, Lorinda, de Jesus, Ranalie, Brookes, Karen, Vargas, Phoebe, McMahon, Caroline, Macor, Chiara, Pasquale, Ciro, Bermperi, Areti, Kourampa, Evgenia, Fabiculcana, Marivic, Zerudo, Julie Ann, Mendoza, Vivien, Fuller, Stewart, Glemas, Claire, Baker, Sharon, Lyons, Greta, Bishop, Marina, Coleman, Siobhan, Thomas, Naomi, Mlilo, Vince, Stanton, Edward, Michel, Rachel, Philips, Julie, Rice, Heidi, Garner, Lucie, Rosa, Francesca, Victor, Saji, Zamikula, Julie, Mepham, Sue, Hajee, Fatima, Quijano-Campos, Juan Carlos, Watson, Laura, Georgiou, Christopher, Worsley, Jieniean, Shamtally-Amode, Djamilla, Rahimi, Ferishta, Jones, Heather, Cruz, Isabel, Lindsay, Gayle, Sparke, Christian, Chapman, Anna, Keating-Fedders, Katie, Fahey, Codie, Johnson, Danielle, Worboys, Lucy, Hargreaves, Simone, Bucke, Ashlea, Carr, Lindsay, Hampshire, Jackie, Richardson, Tracy, Sharpe, Jenny, Whitehead, Lynne, Vyse, Naval, Kelleher, Stephen, Sherwood, Mary-Beth, Hughes, Vicki, Giraud, Kim

“…The COVID-19 pandemic has resulted in unprecedented challenges for healthcare systems worldwide. It has also stimulated research in a wide range of areas…”
Get full text

A Study of Streptococci Producing Positive Hotis Reactions1 by McCulloch, Ernest C., Fuller, Stewart A.

Get full text

A Study of Streptococci Producing Positive Hotis Reactions by McCulloch, E C, Fuller, S A

Get full text